| . | KT 1978–1999 . | KT 2000–2013 . | All cases . | P-value, before and after 2000 . |
|---|---|---|---|---|
| Patients, n | 68 | 121 | 189 | |
| sCr before pregnancy | 1.05 (0.51–1.8) | 1.07 (0.6–2.4) | 1.07 (0.51–2.4) | 0.993 |
| sCr 20 weeks | 0.9 (0.5–1.9) N = 53 | 0.9 (0.4–2.3) N = 93 | 0.9 (0.4–2.3) N = 146 | 0.642 |
| sCr 6 months after delivery | 1.0 (0.4–2.1) N = 55 | 1.0 (0.6–2.5) N = 89 | 1.0 (0.4–2.5) N = 144 | 0.749 |
| sCr 1 year after delivery | 1.1 (0.4–2.1) N = 61 | 1.1 (0.5–2.6) N = 102 | 1.1 (0.4–2.6) N = 163 | 0.543 |
| eGFR CKD-EPI before pregnancy | 72 (36–129) | 71 (25–123) | 71 (25–129) | 0.473 |
| eGFR CKD-EPI 20 weeks | 86 (36–132) N = 53 | 80 (27–133) N = 93 | 82 (27–133) N = 146 | 0.238 |
| eGFR CKD-EPI 6 months after delivery | 73 (31–142) N = 55 | 71 (24–123) N = 89 | 71.5 (24–142) N = 144 | 0.425 |
| eGFR CKD-EPI 1 year after delivery | 67 (31–141) N = 61 | 66.5 (22–133) N = 102 | 67 (22–141) N = 163 | 0.997 |
| CKD-EPI stages before pregnancy | ||||
| Stage 1 | 14/68 (20.6%) | 26/121 (21.5%) | 40/189 (21.2%) | 0.487 |
| Stage 2 | 36/68 (52.9%) | 52/121 (43.0%) | 88/189 (46.6%) | |
| Stage 3 | 18/68 (26.5%) | 42/121 (34.7%) | 60/189 (31.7%) | |
| Stages 4–5 | – | 1/121 (0.8%) | 1/189 (0.5%) | |
| CKD-EPI stages 1 year after delivery | ||||
| Stage 1 | 7/61 (11.5%) | 17/102 (16.7%) | 24/163 (14.7%) | 0.188 |
| Stage 2 | 36/61 (59.0%) | 48/102 (47.1%) | 84/163 (51.5%) | |
| Stage 3 | 18/61 (29.5%) | 32/102 (31.4%) | 50/163 (30.7%) | |
| Stages 4–5 | – | 5/102 (4.9%) | 5/163 (3.1%) | |
| . | KT 1978–1999 . | KT 2000–2013 . | All cases . | P-value, before and after 2000 . |
|---|---|---|---|---|
| Patients, n | 68 | 121 | 189 | |
| sCr before pregnancy | 1.05 (0.51–1.8) | 1.07 (0.6–2.4) | 1.07 (0.51–2.4) | 0.993 |
| sCr 20 weeks | 0.9 (0.5–1.9) N = 53 | 0.9 (0.4–2.3) N = 93 | 0.9 (0.4–2.3) N = 146 | 0.642 |
| sCr 6 months after delivery | 1.0 (0.4–2.1) N = 55 | 1.0 (0.6–2.5) N = 89 | 1.0 (0.4–2.5) N = 144 | 0.749 |
| sCr 1 year after delivery | 1.1 (0.4–2.1) N = 61 | 1.1 (0.5–2.6) N = 102 | 1.1 (0.4–2.6) N = 163 | 0.543 |
| eGFR CKD-EPI before pregnancy | 72 (36–129) | 71 (25–123) | 71 (25–129) | 0.473 |
| eGFR CKD-EPI 20 weeks | 86 (36–132) N = 53 | 80 (27–133) N = 93 | 82 (27–133) N = 146 | 0.238 |
| eGFR CKD-EPI 6 months after delivery | 73 (31–142) N = 55 | 71 (24–123) N = 89 | 71.5 (24–142) N = 144 | 0.425 |
| eGFR CKD-EPI 1 year after delivery | 67 (31–141) N = 61 | 66.5 (22–133) N = 102 | 67 (22–141) N = 163 | 0.997 |
| CKD-EPI stages before pregnancy | ||||
| Stage 1 | 14/68 (20.6%) | 26/121 (21.5%) | 40/189 (21.2%) | 0.487 |
| Stage 2 | 36/68 (52.9%) | 52/121 (43.0%) | 88/189 (46.6%) | |
| Stage 3 | 18/68 (26.5%) | 42/121 (34.7%) | 60/189 (31.7%) | |
| Stages 4–5 | – | 1/121 (0.8%) | 1/189 (0.5%) | |
| CKD-EPI stages 1 year after delivery | ||||
| Stage 1 | 7/61 (11.5%) | 17/102 (16.7%) | 24/163 (14.7%) | 0.188 |
| Stage 2 | 36/61 (59.0%) | 48/102 (47.1%) | 84/163 (51.5%) | |
| Stage 3 | 18/61 (29.5%) | 32/102 (31.4%) | 50/163 (30.7%) | |
| Stages 4–5 | – | 5/102 (4.9%) | 5/163 (3.1%) | |
Data expressed as median (minimum-maximum); sCr: serum creatinine; eGFR: estimated glomerular filtration rate; CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration; KT: kidney transplantation.
In 1978–99: information on outcomes available in 45 cases. Dialysis was restarted by 25 women after delivery (none within the first year); 6 mothers died (none in the first year after delivery).
In 2000–13: dialysis was restarted by 9 women after delivery (one only within the first year); 2 mothers died (1 after dialysis start, 2 years after delivery, and one 3 years after delivery).
| . | KT 1978–1999 . | KT 2000–2013 . | All cases . | P-value, before and after 2000 . |
|---|---|---|---|---|
| Patients, n | 68 | 121 | 189 | |
| sCr before pregnancy | 1.05 (0.51–1.8) | 1.07 (0.6–2.4) | 1.07 (0.51–2.4) | 0.993 |
| sCr 20 weeks | 0.9 (0.5–1.9) N = 53 | 0.9 (0.4–2.3) N = 93 | 0.9 (0.4–2.3) N = 146 | 0.642 |
| sCr 6 months after delivery | 1.0 (0.4–2.1) N = 55 | 1.0 (0.6–2.5) N = 89 | 1.0 (0.4–2.5) N = 144 | 0.749 |
| sCr 1 year after delivery | 1.1 (0.4–2.1) N = 61 | 1.1 (0.5–2.6) N = 102 | 1.1 (0.4–2.6) N = 163 | 0.543 |
| eGFR CKD-EPI before pregnancy | 72 (36–129) | 71 (25–123) | 71 (25–129) | 0.473 |
| eGFR CKD-EPI 20 weeks | 86 (36–132) N = 53 | 80 (27–133) N = 93 | 82 (27–133) N = 146 | 0.238 |
| eGFR CKD-EPI 6 months after delivery | 73 (31–142) N = 55 | 71 (24–123) N = 89 | 71.5 (24–142) N = 144 | 0.425 |
| eGFR CKD-EPI 1 year after delivery | 67 (31–141) N = 61 | 66.5 (22–133) N = 102 | 67 (22–141) N = 163 | 0.997 |
| CKD-EPI stages before pregnancy | ||||
| Stage 1 | 14/68 (20.6%) | 26/121 (21.5%) | 40/189 (21.2%) | 0.487 |
| Stage 2 | 36/68 (52.9%) | 52/121 (43.0%) | 88/189 (46.6%) | |
| Stage 3 | 18/68 (26.5%) | 42/121 (34.7%) | 60/189 (31.7%) | |
| Stages 4–5 | – | 1/121 (0.8%) | 1/189 (0.5%) | |
| CKD-EPI stages 1 year after delivery | ||||
| Stage 1 | 7/61 (11.5%) | 17/102 (16.7%) | 24/163 (14.7%) | 0.188 |
| Stage 2 | 36/61 (59.0%) | 48/102 (47.1%) | 84/163 (51.5%) | |
| Stage 3 | 18/61 (29.5%) | 32/102 (31.4%) | 50/163 (30.7%) | |
| Stages 4–5 | – | 5/102 (4.9%) | 5/163 (3.1%) | |
| . | KT 1978–1999 . | KT 2000–2013 . | All cases . | P-value, before and after 2000 . |
|---|---|---|---|---|
| Patients, n | 68 | 121 | 189 | |
| sCr before pregnancy | 1.05 (0.51–1.8) | 1.07 (0.6–2.4) | 1.07 (0.51–2.4) | 0.993 |
| sCr 20 weeks | 0.9 (0.5–1.9) N = 53 | 0.9 (0.4–2.3) N = 93 | 0.9 (0.4–2.3) N = 146 | 0.642 |
| sCr 6 months after delivery | 1.0 (0.4–2.1) N = 55 | 1.0 (0.6–2.5) N = 89 | 1.0 (0.4–2.5) N = 144 | 0.749 |
| sCr 1 year after delivery | 1.1 (0.4–2.1) N = 61 | 1.1 (0.5–2.6) N = 102 | 1.1 (0.4–2.6) N = 163 | 0.543 |
| eGFR CKD-EPI before pregnancy | 72 (36–129) | 71 (25–123) | 71 (25–129) | 0.473 |
| eGFR CKD-EPI 20 weeks | 86 (36–132) N = 53 | 80 (27–133) N = 93 | 82 (27–133) N = 146 | 0.238 |
| eGFR CKD-EPI 6 months after delivery | 73 (31–142) N = 55 | 71 (24–123) N = 89 | 71.5 (24–142) N = 144 | 0.425 |
| eGFR CKD-EPI 1 year after delivery | 67 (31–141) N = 61 | 66.5 (22–133) N = 102 | 67 (22–141) N = 163 | 0.997 |
| CKD-EPI stages before pregnancy | ||||
| Stage 1 | 14/68 (20.6%) | 26/121 (21.5%) | 40/189 (21.2%) | 0.487 |
| Stage 2 | 36/68 (52.9%) | 52/121 (43.0%) | 88/189 (46.6%) | |
| Stage 3 | 18/68 (26.5%) | 42/121 (34.7%) | 60/189 (31.7%) | |
| Stages 4–5 | – | 1/121 (0.8%) | 1/189 (0.5%) | |
| CKD-EPI stages 1 year after delivery | ||||
| Stage 1 | 7/61 (11.5%) | 17/102 (16.7%) | 24/163 (14.7%) | 0.188 |
| Stage 2 | 36/61 (59.0%) | 48/102 (47.1%) | 84/163 (51.5%) | |
| Stage 3 | 18/61 (29.5%) | 32/102 (31.4%) | 50/163 (30.7%) | |
| Stages 4–5 | – | 5/102 (4.9%) | 5/163 (3.1%) | |
Data expressed as median (minimum-maximum); sCr: serum creatinine; eGFR: estimated glomerular filtration rate; CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration; KT: kidney transplantation.
In 1978–99: information on outcomes available in 45 cases. Dialysis was restarted by 25 women after delivery (none within the first year); 6 mothers died (none in the first year after delivery).
In 2000–13: dialysis was restarted by 9 women after delivery (one only within the first year); 2 mothers died (1 after dialysis start, 2 years after delivery, and one 3 years after delivery).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
